✦ LIBER ✦

Reduction in labile plasma iron during treatment with deferasirox, a once-daily oral iron chelator, in heavily iron-overloaded patients with β-thalassaemia

✍ Scribed by Shahina Daar; Anil Pathare; Hanspeter Nick; Ulrike Kriemler-Krahn; Abdel Hmissi; Dany Habr; Ali Taher

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of deferasirox, an o

✍ Ali Taher; Amal El-Beshlawy; Mohsen S. Elalfy; Kusai Al Zir; Shahina Daar; Dany 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB

Long-term experience with deferasirox (I

✍ Cappellini, MD; Taher, A 📂 Article 📅 2008 🏛 Informa plc 🌐 English ⚖ 305 KB

Normal pregnancy in a patient with β-tha

✍ Dimitra Vini; Philippos Servos; Marouso Drosou 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Evaluation of ICL670, a Once-Daily Oral

✍ RENZO GALANELLO 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

Increased serum hepcidin levels during t

✍ Hussam Ghoti; Eitan Fibach; Mark Westerman; Olbina Gordana; Tomas Ganz; Eliezer 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

Prospective evaluation of patient-report

✍ Maria Domenica Cappellini; Mohamed Bejaoui; Leyla Agaoglu; John Porter; Thomas C 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 628 KB